PDE4 inhibitors work by keeping cyclic AMP levels high inside inflammatory cells, which reduces inflammation in the airway. Only one of the four drugs here uses this mechanism.
The PDE4-blocking, COPD-approved drug among these four is roflumilast.
So the correct answer is Roflumilast.
The linking of the antibiotic resistance gene with the plasmid vector of Salmonella typhimurium by Stanley Cohen and Herbert Boyer was made possible by the enzyme: